371 filings
Page 2 of 19
6-K
TLSA
Tiziana Life Sciences Ltd
1 Dec 23
To Be Held As a “Remote Meeting” Only
9:00am
6-K
TLSA
Tiziana Life Sciences Ltd
30 Nov 23
Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis
7:08am
6-K
TLSA
Tiziana Life Sciences Ltd
1 Nov 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
18 Oct 23
Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment
7:12am
6-K
TLSA
Tiziana Life Sciences Ltd
16 Oct 23
Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
13 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
11 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
26 Sep 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
8 Sep 23
Tiziana Life Sciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
6 Sep 23
Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance
7:00am
424B5
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Prospectus supplement for primary offering
5:16pm
6-K
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Report of Foreign Private Issuer
4:46pm
6-K
TLSA
Tiziana Life Sciences Ltd
23 Aug 23
Tiziana Life Sciences Announces Appointment of William A. Clementi as Chief Development Officer
10:30am
6-K
TLSA
Tiziana Life Sciences Ltd
23 Aug 23
Tiziana Life Sciences Announces Foralumab Presentation by Dr. Howard Weiner at the Annual Meeting of the International Society of Neuroimmunology
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
17 Aug 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
15 Aug 23
Tiziana Life Sciences Announces FDA IND Clearance of Intranasal Foralumab for the Treatment of Alzheimer’s Disease
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
21 Jul 23
Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice
4:15pm
20-F/A
2022 FY
TLSA
Tiziana Life Sciences Ltd
13 Jun 23
Annual report (foreign) (amended)
12:37pm
6-K
TLSA
Tiziana Life Sciences Ltd
13 Jun 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
5 Jun 23
Report of Foreign Private Issuer
10:29am